AEON Biopharma AEON
NYSE AEON
$0.23 +0.00 (+1.26%)
As of: Oct 20, 2026 · 3:59 PM EDT

AEON Biopharma (AEON) Operating Leases (2022 - 2026)

Updated

AEON Biopharma (AEON) recorded Operating Leases of $757,000 in Q2 2026, down 25.8% from $1.02 million a year earlier.

Analysis

AEON Biopharma (AEON) Operating Leases (2022 - 2026) Analysis & Trends

At the end of FY2025, AEON Biopharma reported Operating Leases of $893,000, down 22.0% from FY2024.

  • Annual Operating Leases has a three-year compound annual growth rate of 54.5% (FY2022 to FY2025).
  • Across earlier years, Operating Leases came in at $1.15 million in FY2024 and $242,000 in FY2022.
  • The Q2 2026 figure is the lowest quarterly Operating Leases since Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 AEON Biopharma 11.93 Mn -8.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 757,000.00
Dec 31, 2025 893,000.00
Sep 30, 2025 957,000.00
Jun 30, 2025 1.02 Mn
Mar 31, 2025 1.08 Mn
Dec 31, 2024 1.15 Mn
Sep 30, 2024 1.20 Mn
Jun 30, 2024 1.26 Mn
Sep 30, 2023 52,000.00
Dec 31, 2022 242,000.00
API Access

AEON Biopharma Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=AEON&period=max&api_key=YOUR_API_KEY